My research revolves around investigating novel ligands and biological functions of a group of endocytic proteins, the Mannose Receptor Family. The aim is to further clarify the role of these receptors in health and pathological conditions, including cancer invasion and metastasis.

A particular focus during my post.doc is the development and investigation of the utilization of a class of targeted cancer drugs, antibody-drug-conjugates. The efficacy of these new drugs is investigated using a variety of in vitro and in vivo studies in mouse cancer models.

EDUCATION:

Aug '12 Dec '12: Semester abroad, National University of Singapore, Singapore.

Feb. '14: Bsc. in Molecular Biomedicine, University of Copenhagen, Denmark.

Bachelor’s Thesis: Characterization of WDTC1, a Potential New Component of the Intraflagellar Transport Complex.

Supervisor: Lotte Bang Pedersen.

Carried out at the section for Cell and Developmental Biology, Department of Biology, University of Copenhagen, 01/13-06/13.

Nov. '15: Msc. in Molecular Biomedicine, University of Copenhagen, Denmark.

Master’s Thesis: Investigating Novel Ligands of the Endocytic Collagen Receptors of the Mannose Receptor Protein Family.

Supervisor: Niels Behrendt.

Carried out at the Finsen Laboratory, Rigshospitalet/BRIC, University of Copenhagen, Denmark, 04/14-11/15.

Sep. '20: PhD in Molecular Mechanisms of Disease
Dissertation: A Survey of Novel Ligands of the Members of the Mannose Receptor Protein Family

WORK EXPERIENCE:

Jan. '16 - April '16: Research assistant, Behrendt group, Finsen Laboratory, Rigshospitalet/BRIC, University of Copenhagen.

Apr. '16-Sep. '20: PhD student, Behrendt group, Finsen Laboratory, Rigshospitalet/BRIC, University of Copenhagen.

Okt '20-present: Post. Doc, Behrendt group, Finsen Laboratory, Rigshospitalet/BRIC, University of Copenhagen.

My research revolves around investigating novel ligands and biological functions of a group of endocytic proteins, the Mannose Receptor Family. The aim is to further clarify the role of these receptors in health and pathological conditions, including cancer invasion and metastasis.

A particular focus during my post.doc is the development and investigation of the utilization of a class of targeted cancer drugs, antibody-drug-conjugates. The efficacy of these new drugs is investigated using a variety of in vitro and in vivo studies in mouse cancer models.